GlassScriptPhysician profile
Vincent Alan Chavanon
NPI 1548502396
$20,672.31
in general payments reported to CMS, 2019-2025
35 companies · $9,024 in 2025
The $9,024 reported for 2025 was more than what 95% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $3,585 · 2021: $486 · 2022: $1,214 · 2023: $1,659 · 2024: $4,591 · 2025: $9,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,776 · Travel and Lodging: $7,171 · Long Term Medical Supply Or Device Loan: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,776.40 |
| Travel and Lodging | $7,171.41 |
| Long Term Medical Supply Or Device Loan | $325.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $4,206.73 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Protector, Axoguard Nerve Connector |
| Tela Bio, INC. | $3,649.42 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Mentor Worldwide LLC | $2,319.86 | 2023-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Mentor Siltex Round Spectrum |
| Trimed, INC. | $2,256.61 | 2020 | |
| Abbvie INC. | $1,993.85 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Integra Lifesciences Corporation | $1,217.85 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Surgimend |
| Southern Edge Orthopaedics, INC. | $1,067.00 | 2020 | |
| Motiva USA, LLC | $825.10 | 2024-2025 | |
| Stryker Corporation | $754.60 | 2022-2025 | Variax, Gamma, T2 Alpha |
| Allergan, INC. | $563.24 | 2020-2022 | |
| Polynovo North America LLC | $269.40 | 2025 | Novosorb Btm |
| Sientra, INC. | $243.98 | 2021-2022 | |
| Davol INC. | $228.90 | 2022-2025 | Phasix Mesh, Arista Ah Flexitip |
| Endo Pharmaceuticals INC. | $113.33 | 2019 | |
| Organogenesis INC. | $109.46 | 2025 | Puraply Wound Matrix |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acera Surgical, INC. | $94.26 | 2021-2025 | Restrata Wound Matrix |
| Musculoskeletal Transplant Foundation INC. | $86.61 | 2022 | |
| Smith+Nephew, INC. | $76.86 | 2022-2025 | Collagenase Santyl, Renasys Go V2 Home |
| Kls-Martin L.P. | $76.73 | 2024 | |
| Dilon Technologies, INC. | $70.50 | 2024 | Hemoblast Bellows |
| Endomagnetics LTD | $70.48 | 2023 | Magseed, Magtrace |
| Avita Medical Americas, LLC | $65.57 | 2025 | Permeaderm, Cohealyx, Recell |
| Trice Medical, INC. | $50.00 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $45.24 | 2024-2025 | Exparel |
| Depuy Synthes Sales INC. | $43.81 | 2025 | Matrixmandible |
| Biocircuit Technologies INC | $32.93 | 2025 | Nerve Tape |
| Merz North America, INC. | $25.41 | 2020 | |
| Bard Peripheral Vascular, INC. | $22.75 | 2021 | |
| Innovation Technologies INC | $18.27 | 2024 | Irrisept |
| Baxter Healthcare | $16.75 | 2023 | Tisseel |
| Guard Medical INC. | $13.66 | 2025 | Npseal |
| Bioventus LLC | $12.52 | 2022 | |
| Galderma Laboratories, L.P. | $12.19 | 2021 | |
| C2dx, INC | $10.35 | 2022 | |
| Heraeus Medical, LLC. | $8.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Chavanon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.